MedTrace Logo

Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia

NCT04411849 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 802

Last updated 2025-09-10

Study results available
· View outcomes & findings →

Summary

This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.

Conditions

  • Cervical Carcinoma
  • Human Papillomavirus Infection

Interventions

OTHER

Best Practice

Receive usual care

PROCEDURE

HPV Self-Collection

Receive HPV self-testing intervention

OTHER

Informational Intervention

Receive information about cervical cancer

BEHAVIORAL

Patient Navigation Program

Receive telephone-based patient navigation

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Paul Reiter, PhD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-27
Primary Completion
2024-06-11
Completion
2024-06-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04411849 on ClinicalTrials.gov